We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Canada-based healthcare biotechnology company Entos Pharmaceuticals announced their development of a DNA vaccine to prevent COVID-19 using its Fusogenix drug delivery platform.